Deacon Associates Acquires 31 Hospice, Home Health Agencies From HCA Healthcare

Bypaulgruensfelder
HOSPICE NEWS June 24, 2026
Read Full Article →
AI-Generated Summary

Deacon Associates has agreed to acquire 31 home health and hospice agencies from HCA Healthcare, with hospice representing 23% of the divested assets across eight states. The deal, expected to close within roughly three months pending regulatory approval, extends a consolidation thread that traces back to HCA’s 2021 acquisition of an 80% stake in Brookdale Senior Living’s home health and hospice segment for $400 million. Deacon CEO Trey Crabb said the move reflects a deliberate strategy to scale: growing larger lets the company spread fixed costs over a bigger operating base while reimbursement rates decline and care delivery costs rise. Financial terms of the new transaction were not disclosed.

Why It Matters

Hospital systems are continuing to exit post-acute lines while specialized roll-ups absorb the volume, a clear signal for hospice and home health operators that scale and cost-spreading, not organic growth alone, are becoming the dominant playbook for surviving reimbursement pressure.

hospice M&A home health consolidation HCA Healthcare divestiture post-acute care strategy PE roll-up reimbursement pressure

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

Why is HCA Healthcare selling off its hospice and home health agencies?

HCA Healthcare divested 31 home health and hospice agencies across eight states to Deacon Associates, with hospice representing 23% of the divested assets. The move continues HCA’s pullback from post-acute care after entering the space via its 2021, $400 million acquisition of an 80% stake in Brookdale Senior Living’s home health and hospice segment.

What is Deacon Associates’ strategy behind the HCA Healthcare acquisition?

Deacon Associates CEO Trey Crabb said the deal reflects a decision to ‘double down’ on home health and hospice by scaling up, spreading fixed costs over a larger operating base as reimbursement rates decline and care delivery costs climb. The acquisition is expected to close in about three months pending regulatory approval.

How big was the 2021 HCA-Brookdale home health and hospice deal?

HCA Healthcare acquired an 80% stake in Brookdale Senior Living’s home health and hospice services segment in 2021 for $400 million. Several assets from that earlier transaction are included among the 31 agencies now being divested to Deacon Associates.

Similar Posts

  • Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics

    Bypaulgruensfelder

    Four major forces are reshaping DSO growth in 2026: private equity resurging in oral surgery (up 9.1% in PE deals), medical-dental integration expanding through health system partnerships, AI adoption at scale across patient communication and operations, and salivary diagnostics emerging as a clinical frontier. For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating — and what capabilities will separate market leaders from laggards through 2027.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Bypaulgruensfelder

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.